Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Surgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patients.

Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):912-9. doi: 10.1097/MEG.0b013e32835fa668.

PMID:
23470356
2.

Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.

Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH.

Korean J Intern Med. 2013 Jul;28(4):428-38. doi: 10.3904/kjim.2013.28.4.428.

3.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4.

PMID:
19506976
4.

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.

Du M, Chen L, Zhao J, Tian F, Zeng H, Tan Y, Sun H, Zhou J, Ji Y.

BMC Cancer. 2014 Jan 24;14:38. doi: 10.1186/1471-2407-14-38.

5.

Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.

Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH, You YK.

World J Gastroenterol. 2014 Dec 7;20(45):17132-40. doi: 10.3748/wjg.v20.i45.17132.

6.

Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC.

Ma C, Chi M, Su H, Cheng X, Chen L, Kan Y, Wei W, Huang X, Li Y, Li L, Lin K, Huang Y, Wu Y, Huang X, Huang A, Liu J.

Hepatogastroenterology. 2012 Oct;59(119):2104-11. doi: 10.5754/hge12109.

PMID:
23435129
7.

Hepatic resection for hepatocellular carcinoma in the elderly.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

J Am Coll Surg. 2001 Jan;192(1):38-46.

PMID:
11192921
8.

Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.

Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK.

Transplant Proc. 2012 Mar;44(2):487-93. doi: 10.1016/j.transproceed.2011.11.009.

PMID:
22410053
9.

The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.

Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T.

J Clin Gastroenterol. 2013 Apr;47(4):359-66. doi: 10.1097/MCG.0b013e31826be9ad.

PMID:
23090049
10.
11.

Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.

Zhao WC, Zhang HB, Yang N, Fu Y, Qian W, Chen BD, Fan LF, Yang GS.

World J Gastroenterol. 2012 Jul 7;18(25):3272-81. doi: 10.3748/wjg.v18.i25.3272.

12.

Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.

Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK.

Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404.

PMID:
25916071
13.

Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

McHugh PP, Gilbert J, Vera S, Koch A, Ranjan D, Gedaly R.

HPB (Oxford). 2010 Feb;12(1):56-61. doi: 10.1111/j.1477-2574.2009.00128.x.

14.

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.

Jiang JH, Guo Z, Lu HF, Wang XB, Yang HJ, Yang FQ, Bao SY, Zhong JH, Li LQ, Yang RR, Xiang BD.

World J Gastroenterol. 2015 Apr 21;21(15):4627-34. doi: 10.3748/wjg.v21.i15.4627.

15.

Living donor liver transplantation for hepatocellular carcinoma.

Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S.

Transplant Proc. 2012 Jul-Aug;44(6):1713-6. doi: 10.1016/j.transproceed.2012.05.033.

PMID:
22841251
16.

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.

Toshikuni N, Takuma Y, Goto T, Yamamoto H.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2361-6. doi: 10.5754/hge12934.

PMID:
23169175
17.

A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.

Xia Y, Yan ZL, Xi T, Wang K, Li J, Shi LH, Wu MC, Shen F.

Hepatogastroenterology. 2012 Oct;59(119):2248-54.

PMID:
22366528
18.

Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.

Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y, Tanigawa N.

Am Surg. 2011 May;77(5):572-8.

PMID:
21679590
19.

Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.

Li J, Huang L, Liu CF, Cao J, Yan JJ, Xu F, Wu MC, Yan YQ.

World J Gastroenterol. 2014 Jul 21;20(27):9121-7. doi: 10.3748/wjg.v20.i27.9121.

20.

[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers].

Silva M, Mattos AA, Fontes PR, Waechter FL, Pereira-Lima L.

Arq Gastroenterol. 2008 Apr-Jun;45(2):99-105. Portuguese.

Items per page

Supplemental Content

Support Center